Why the study?
Does sugammadex reduce major postoperative pulmonary complications in adult patients undergoing inpatient surgery compared to neostigmine?
Does sugammadex reduce major postoperative pulmonary complications in adult patients undergoing inpatient surgery compared to neostigmine?
Sugammadex is associated with a lower incidence of major postoperative pulmonary complications compared to neostigmine in adults undergoing inpatient surgery.
May lower major pulmonary complications versus neostigmine; hypothesis-generating and requires RCTs before practice change.
Among a generalizable cohort of adult patients undergoing inpatient surgery at U.S. hospitals, the use of sugammadex was associated with a clinically and statistically significant lower incidence of major pulmonary complications.
No takes yet. Share an insight, caveat, or question.
Kheterpal et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: